| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.066 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |